Fresenius Medical Care stock slips 1.10% ahead of Q3 results

Published on 11/02/2026 at 15:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius Medical Care stock heads into Tuesday's Q3 results after a lower latest quote. The company has confirmed its 2026 outlook.

FMC approaches its next results

Fresenius Medical Care is scheduled to publish third-quarter results on Tuesday, November 3, 2026.
The company has confirmed its 2026 outlook after strong operating profit growth in the second quarter.
The quarterly financial report is scheduled for Friday, November 6, 2026.

FMC, DE0005785802, Illustration mit AI erstellt.

Fresenius Medical Care stock slipped 1.10% from the quote in our October 30 report as investors approached Tuesday's third-quarter results. At 3:39 p.m. CET on Monday, November 2, 2026, Fresenius Medical Care stock traded at 40.44 euros on Lang & Schwarz, compared with 40.89 euros in the earlier report.

What has changed since our last report

The move provides a fresh market reference ahead of the company's next operating update. The comparison is separate from the daily Xetra close and reflects the change between the two Lang & Schwarz observations.

Fresenius Medical Care's investor calendar schedules publication of the third-quarter 2026 results for Tuesday, November 3, followed by the quarterly financial report on Friday, November 6. The company website also states that the 2026 outlook remains confirmed after the first half.

Results will test the outlook

The second-quarter update cited solid organic revenue growth and improved profitability. Fresenius Medical Care said underlying operating income improved by 34% in the Care Delivery segment after adjustment for positive TDAPA effects, with higher reimbursement rates and revenue-cycle improvements supporting the development.

The company is also expanding the 5008X CAREsystem in the United States. Its investor materials said the technology was available in 227 US clinics and had been used in more than 600,000 treatments at the time of the update.

Investors can follow the real-time quote of Fresenius Medical Care stock during the results week.

The Fresenius Medical Care investor calendar is the source for the scheduled reporting dates and the company's outlook statement. The next results release will provide the clearest test of operating momentum, reimbursement effects and margin progress.

The DAX market backdrop remains relevant for German large-cap stocks; investors can follow current DAX market developments.

More coverage is available in more news and analyses on Fresenius Medical Care stock.